Revenue of Shanghai Pharmaceuticals 2017-2022, by region
In 2022, Shanghai Pharmaceutical Group (SPGC) generated a revenue of approximately 228 billion yuan from its domestic core business in China. SPGC is a listed company in Shanghai and Hong Kong and a leading player in the Chinese pharmaceutical market.